An all-in-one, easy to use bubble CPAP that gives breathing support to babies experiencing respiratory distress.

Request Information

The Innovation

The Pumani bubbleCPAP is used to treat respiratory distress syndrome (RDS) in premature neonates and respiratory illness in young children from 1 to 10 kg. Designed specifically for the low-resource hospitals, it is an effective, affordable and user-friendly solution currently in use in over 35 countries around the world.

Effective & Affordable

Provides the same level of therapeutic pressure as other commercial CPAPs for less than one-third of the price.

User Friendly

Set-up training takes less than 5 minutes

Easy to Maintain

Minimal maintenance, a spare parts kit is included inside unit

Durable

Built and proven to run for years at a time

Specifications

Oxygen Blending

21-90%

Gas Supply

Integrated Air Compressor

Total (blended) Flow Rate

0-10 L/min

Oxygen Flow Rate

0-10 L/min

Pressure

0-10 cm H20

Voltage

220V and 50Hz

Power Consumption

15 W

Shipping Dimensions

48 cm x 38 cm x 33 cm

Shipping Weight

12kg

Regulatory Compliance

CE Mark

Accessories

Bottles, Filters

Pumani Patient Circuit Kit - 10 x Complete Patient Circuits including Patient Tubing, Tube Holders, Fish Elbows, Hats & Hat Clips, Nasal Prongs

Components

One Pumani bubbleCPAP package comes with the following items:

1 Pumani bubbleCPAP device
2 Bottle (1)
3 Inspiratory Tubing (3)
4 Expiratory Tubing (3)
5 Fish Elbows (6)
6 Hat Clips (6)
7 Tubing Clip (3)
8 Variety of Nasal Prongs (6 prongs, sizes 0-5)
9 Hats (3 hats, size small, medium, large)
10 Power Cord – UK Plug (1)
11 Spare parts kit (not shown)
12 User Manual and Repair Manual (not shown)
13 Online Training Videos and Materials (not shown)

Additional accessories can be purchased separately.

Pumani means ‘breathe easy’ in Chichewa, the language of Malawi.

Pumani Clinical Study

In 2012, results of the Pumani clinical trial conducted at Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi, showed that use of the Pumani to treat neonatal respiratory distress resulted in 27% absolute improvement in survival, as compared to patients treated with oxygen therapy.

Screen Shot 2020-06-16 at 9.54.32 AM.png

Survival Rates for Neonates with Respiratory Distress

Impact

Pumani units have been distributed to over 35 countries worldwide.
The Pumani bubbleCPAP is recognized by the Million Lives Collective for its health impacts on over a million babies.

Development

The Development of Pumani has been a collaboration between Hadleigh Health Technologies, Rice University, Queen Elizabeth Central Hospital, the Malawian Ministry of Health, and Texas Children’s Hospital. Based on the results from clinical testing, the Pumani partners received additional funding to distribute Pumani units to every public central and district hospital in Malawi.